TRIP10
Cdc42-interacting protein 4
Also known as: CIP4, CIP4_HUMAN, HSTP, STOT, STP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15642
- Gene
- TRIP10
- Ensembl
- ENSG00000125733
- Chromosome
- 19
- Canonical length
- 601 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables identical protein binding activity. Predicted to be involved in actin cytoskeleton organization and signal transduction. Located in nucleoplasm. Biomarker of Huntington's disease. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
601 residues, UniProt reviewed canonical sequence.
>Q15642|TRIP10
1 MDWGTELWDQ FEVLERHTQW GLDLLDRYVK FVKERTEVEQ AYAKQLRSLV KKYLPKRPAK
61 DDPESKFSQQ QSFVQILQEV NDFAGQRELV AENLSVRVCL ELTKYSQEMK QERKMHFQEG
121 RRAQQQLENG FKQLENSKRK FERDCREAEK AAQTAERLDQ DINATKADVE KAKQQAHLRS
181 HMAEESKNEY AAQLQRFNRD QAHFYFSQMP QIFDKLQDMD ERRATRLGAG YGLLSEAELE
241 VVPIIAKCLE GMKVAANAVD PKNDSHVLIE LHKSGFARPG DVEFEDFSQP MNRAPSDSSL
301 GTPSDGRPEL RGPGRSRTKR WPFGKKNKPR PPPLSPLGGP VPSALPNGPP SPRSGRDPLA
361 ILSEISKSVK PRLASFRSLR GSRGTVVTED FSHLPPEQQR KRLQQQLEER SRELQKEVDQ
421 REALKKMKDV YEKTPQMGDP ASLEPQIAET LSNIERLKLE VQKYEAWLAE AESRVLSNRG
481 DSLSRHARPP DPPASAPPDS SSNSASQDTK ESSEEPPSEE SQDTPIYTEF DEDFEEEPTS
541 PIGHCVAIYH FEGSSEGTIS MAEGEDLSLM EEDKGDGWTR VRRKEGGEGY VPTSYLRVTL
601 NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIP10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 340 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 340 nTPM
- esophagus: 243 nTPM
- tongue: 166 nTPM
- vagina: 142 nTPM
- heart muscle: 117 nTPM
- cervix: 117 nTPM
Single-cell type
- esophageal apical cells: 1,828 nCPM
- esophageal suprabasal cells: 167 nCPM
- epididymal basal cells: 126 nCPM
- ocular epithelial cells: 100 nCPM
- myonuclei: 94 nCPM
- suprabasal keratinocytes: 90 nCPM
Immune cell
- plasmacytoid DC: 27 nTPM
- myeloid DC: 5.2 nTPM
- NK-cell: 2.5 nTPM
- naive B-cell: 1.7 nTPM
- memory B-cell: 1.5 nTPM
- memory CD8 T-cell: 1.1 nTPM
Brain region
- choroid plexus: 15 nTPM
- medulla oblongata: 14 nTPM
- thalamus: 14 nTPM
- hypothalamus: 12 nTPM
- midbrain: 11 nTPM
- cerebral cortex: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRIP10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIP10 as an antibody target. Whether an autoantibody or antibody against TRIP10 could matter depends on whether native TRIP10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIP10 is annotated at the cell surface, where native TRIP10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRIP10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...